Kim, Richard W.
Lam, Megan
Abuabara, Katrina
Simpson, Eric L.
Drucker, Aaron M. http://orcid.org/0000-0002-7388-9475
Article History
Accepted: 12 December 2023
First Online: 12 January 2024
Declarations
:
: Megan Lam, Richard W. Kim, and Aaron M. Drucker conducted the literature search and drafted the manuscript. All authors critically revised and approved the final manuscript.
: No funding was received for conducting this study.
: This study did not use any primary data not available from other sources.
: Dr. Drucker has received compensation from the British Journal of Dermatology (reviewer and section editor), American Academy of Dermatology (guidelines writer), National Eczema Association (grant reviewer), Canadian Dermatology Today (manuscript writer), and Canadian Agency for Drugs and Technologies in Health (consultant). Dr. Simpson reports personal fees from Advances in Cosmetic Medical Derm Hawaii LLC, AbbVie, Amgen, AOBiome LLC, Arcutis Biotherapeutics, Arena Pharmaceuticals, Aslan Pharma, Boehringer Ingelheim USA, Inc., Boston Consulting Group, Bristol Myers Squibb—BMS, Collective Acumen LLC (CA), CorEvitas, Dermira, Eli Lilly, Evelo Biosciences, Evidera, ExcerptaMedica, FIDE, Forte Bio RX, Galderma, GlaxoSmithKline, Incyte, Janssen, Johnson & Johnson, Kyowa Kirin Pharmaceutical Development, Leo Pharm, Medscape LLC, Merck, MauiDerm, MLG Operating, MJH holding, Pfizer, Physicians World LLC, PRImE, Regeneron, Revolutionizing Atopic Dermatitis Inc, Roivant, Sanofi-Genzyme, Trevi therapeutics, Valeant, Vindico Medical education, and WebMD. Dr. Drucker has received research grants to his institution from the National Eczema Association, Eczema Society of Canada, Canadian Dermatology Foundation, Canadian Institutes for Health Research, US National Institutes of Health, and Physicians Services Incorporated Foundation. Dr. Abuabara has received research grants to her institution from the National Eczema Association, the US National Institutes of Health, the LEO Foundation, Pfizer, and Cosmetique Internacional SNC. She has received compensation from TARGET RWE. Dr. Simpson reports grants (or serves as principal investigator role) from AbbVie, Acrotech Biopharma Inc, Amgen, Arcutis, Aslan, Castle Biosciences, CorEvitas, Dermavant, Dermira, Eli Lilly, Incyte, Kymab, Kyowa Kirin, National Jewish Health, Leo, Pfizer, Regeneron, Sanofi, and Target RWE. These potential conflicts of interest have been reviewed and managed by Oregon Health and Science University. Mr. Kim and Dr. Lam have no relevant financial or non-financial interests to disclose.
: This article does not contain animal or human subjects that require approval by an ethics board.
: This article does not discuss any individuals or materials that would require consent for participation.
: This article does not discuss any individuals or materials that would require consent for publication.